Correction to: Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy.
Day JW, Mendell JR, Mercuri E, Finkel RS, Strauss KA, Kleyn A, Tauscher-Wisniewski S, Tukov FF, Reyna SP, Chand DH. Correction to: Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy. Drug Saf. 2022 Feb; 45(2):191-192.